Efficacy and safety of a standardised 500 unit dose of Dysport® (Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: Results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study

Journal of Neurology

Volumn 248, Issue 12, 2001, Pages 1073-1078

  Wissel, J ^a   Kanovsky, P ^b   Ruzicka, E ^c   Bares, M ^b   Hortova, H ^b   Streitova, H ^b   Jech, R ^c   Roth, J ^c   Brenneis, C ^a   Muller J ^a   Schnider, P ^d   Auff, E ^d   Richardson, A ^e   Poewe, W ^a  

^a Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e IPSEN   (France)

Author keywords

Botulinum toxin A; Cervical dystonia; Dose recommendation

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM BOTULINUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECK MUSCLE; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TITRIMETRY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; DYSTONIA; FEMALE; HEAD MOVEMENTS; HEMAGGLUTININS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES;

EID: 0035711378     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170028     Document Type: Article

References (13)

1. Botulinum toxin treatment in spasmodic torticollis
2. Botulinum toxin in cervical dystonia: Low dosage with electromyographic guidance
3. Low dose botulinum toxin in spasmodic torticollis
4. Botulinum toxin treatment for cervical dystonia
5. Clinical correlates of response to botulinum toxin injections
6. Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency
7. Treatment of cervical dystonia, hand spasms and laryngeal dystonia with botulinum toxin
8. A double blind trial of botulinum toxin A in torticollis, with one year follow up
9. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox® in the treatment of cervical dystonia
10. Experience with botulinum toxin in cervical dystonia
11. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®
12. Double blind study of botulinum toxin in spasmodic torticollis
13. Dystonia - A clinical, neuropathological and therapeutic review